Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN101514156A details high-gravity solvent recycling for Naproxen. Achieve cost reduction and supply reliability in pharmaceutical intermediate manufacturing.
Patent CN113652407B reveals a novel carbonyl reductase mutant enabling strict S-selectivity and enhanced activity for cost-effective chiral diol manufacturing.
Patent CN115772077B details Cu/AC catalytic conversion of arabitol. Offers high yield chiral intermediate for pharmaceutical manufacturing with cost efficiency.
Novel Filgotinib synthetic method offers high yield and simplified operation. Reliable supplier for pharmaceutical intermediates with cost-effective scale-up solutions.
Patent CN111705096A reveals enzymatic synthesis for high purity NMN. This method reduces solvent use and enhances supply chain stability for global pharmaceutical buyers.
Novel water-based method for allyl glycosides reduces cost and improves purity for pharmaceutical intermediates manufacturing.
Patent CN111362999B details a novel oxidation method for Epristeride impurity. This report analyzes cost reduction in API manufacturing and high-purity reference standard production.
Patent CN109970568B reveals a room-temperature solid acid catalysis route for dimethyl 3-aminophthalate, offering significant cost reduction and supply chain stability for pharmaceutical manufacturing.
Patent CN105039450A reveals one-step enzymatic route. High purity, scalable process for reliable pharmaceutical intermediate supplier partners seeking significant cost reduction and efficiency.
Patent CN118930491B reveals a novel [3+2] cycloaddition route for high-purity triazole intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN117947113A reveals dynamic kinetic resolution for high purity chiral intermediates. Enables cost reduction in pharmaceutical manufacturing with scalable enzyme catalysis.
Patent CN109897872B reveals enzymatic route for HIV intermediate. High conversion and purity ensure reliable pharmaceutical intermediates supplier capability for global procurement.
Patent CN104263768A reveals Candida biocatalysis for chiral esters. Offers high yield and ee. Reliable supply chain and cost reduction for pharmaceutical manufacturing.
Patent CN109897872B details enzymatic reduction for HIV inhibitor intermediates. High purity and conversion enable cost reduction and reliable supply chain stability for global manufacturers.
Patent CN86105165A details novel cyclohexanealkanoic acids for asthma treatment. Discover cost-effective synthesis routes and reliable supply chain solutions for pharmaceutical intermediates.
Patent CN113024624A details a novel 8-step synthesis of deoxycholic acid from cholic acid, offering significant cost reduction and scalable manufacturing for pharmaceutical applications.
Patent CN118955276A details a novel oxidation-hydrolysis route for 2-bromo-5-hydroxybenzoic acid, offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Novel L-alanine catalyzed route improves yield and purity for KRAS G12C inhibitor intermediates, offering cost-effective scale-up solutions.
Patent CN100351219C details a novel Grignard route for CoQ10, offering significant yield improvements and cost reduction potential for global pharmaceutical manufacturers.
Patent CN112745273A reveals a high-yield synthesis for Nifuratel impurity standards, offering reliable supply chain solutions and cost-effective manufacturing for pharmaceutical quality control.